phosphoddr2 y740 (R&D Systems)
93
Structured Review
R&D Systems
phosphoddr2 y740
Phosphoddr2 Y740, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phosphoddr2+y740/Human+Phospho-DDR1%2FDDR2+(DDR1+Y796%2C+DDR2+Y740)+Antibody/pm38978400-65-13-14
Average 93 stars, based on 30 article reviews
Phosphoddr2 Y740, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phosphoddr2+y740/Human+Phospho-DDR1%2FDDR2+(DDR1+Y796%2C+DDR2+Y740)+Antibody/pm38978400-65-13-14
Average 93 stars, based on 30 article reviews
phosphoddr2 y740 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
other:Article Title: DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Article Snippet: Primary antibodies used: DDR2 (1:1000, PA1879, Boster), Article Title: A highly selective inhibitor of discoidin domain receptor-1 (DDR1-IN-1) protects corneal epithelial cells from YAP/ACSL4-mediated ferroptosis in dry eye. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82171020, 82201150 Background and Purpose: This study investigated the involvement of discoidin domain receptor (DDR) in dry eye and assessed the potential of specific DDR inhibitors as a therapeutic strategy for dry eye by exploring the underlying mechanism.. Experimental Approach: Dry eye was induced in Wistar rats by applying 0.2% benzalkonium chloride (BAC), after which rats were treated topically for 7 days with DDR1-IN-1, a selective inhibitor of DDR1.. Clinical manifestations of dry eye were assessed on Day-7 post-treatment. |